Pierrick Lefranc will succeed Aidan Murphy, Executive Vice President of Technical Operations and member of the Executive Committee, who will retire in March 2026 after 30 years at Ipsen. Since July 2019, Pierrick Lefranc has held the position of Senior Vice President at Ipsen, overseeing global production activities, engineering, and corporate excellence. He joined the group in 2013 and was appointed director of the Signes site in France in 2016. He will bring over 30 years of experience in the pharmaceutical industry. Pierrick Lefranc will be based in Paris and will report directly to David Loew, CEO.
Executive Endorsements
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
David Loew, CEO, expressed his pleasure in welcoming Pierrick Lefranc to the Executive Committee, highlighting his expertise in leadership and strategic transformation. He also thanked Aidan Murphy for his dedication and contribution to transforming Ipsen's technical operations. Pierrick Lefranc expressed his enthusiasm about joining the Executive Committee and his readiness to participate in the ongoing transformation of the group.
"En 2025, Ipsen a enregistré une croissance solide de son chiffre d'affaires et de son résultat opérationnel."
Ipsen a publié ses résultats 2025 et T4 2025: chiffre d'affaires de 3 675,9 millions d'euros, croissance YoY de 8,1%; Résultat opérationnel des activités de 1 294,1 millions d'euros, marge de 35,2%; Résultat net consolidé IFRS de 444,5 millions d'euros; Bénéfice dilué par action IFRS de 5,32 euros; Cash-flow libre de 1 000,6 millions d'euros; Dividende par action de 1,40 euro.
Outlook / guidance
Expected revenue: Une croissance des ventes totales supérieure à 13,0 % à taux de change constant en 2026
Management commentary: Ipsen prévoit en 2026 une croissance des ventes totales supérieure à 13,0% à taux de change constant et une marge opérationnelle des activités supérieure à 35,0%.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
